A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab

JCO Precis Oncol. 2022 Nov:6:e2200006. doi: 10.1200/PO.22.00006.

¹ Kantonsspital St Gallen, Klinik für Medizinische Onkologie und Hämatologie, St Gallen, Switzerland.
² Krankenhaus Nordwest GmbH, Institut für Klinisch-Onkologische Forschung, Frankfurt, Germany.
³ Cancer Research UK Cambridge Centre, Cambridge, United Kingdom.
⁴ Molecular Partners AG, Schlieren, Switzerland.
⁵ NBE-Therapeutics AG/Boehringer Ingelheim, Basel, Switzerland.
⁶ Fung Consulting, Eching, Germany.
⁷ National Center for Tumor Diseases (NCT), Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.

No abstract available

Publication types